According to CCTV News, there are more than 400 cell and gene therapy products in clinical trials in China. Among them, there are only 100 stem cell products.

For RA, it may be possible to induce inflammatory relief through permanent immune tolerance, so as to prevent the continuous deterioration of joint structure and repair existing injuries.

The rapid emergence of stem cell technology provides a new solution for the treatment of bone diseases.

Cell products are expected to join the ranks of advanced therapeutic drugs.

Stem cells have proved to be particularly aesthetically attractive.

FDA is no longer required to report two common but sometimes serious side effects of a small number of CAR-T treatments in order to "minimize the burden on the health care system".

Because stem cells have the potential of multi-directional differentiation and the ability of self-renewal, they can form primordial cells of various human organs and tissues, which are called "omnipotent cells" in medical circles.

In 2006, Professor Shinya Yamanaka of Kyoto University in Japan implanted four viruses into mouse skin cells and successfully induced omnipotent differentiated cells.